Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,406 | 13,178 | 15,172 | 16,384 | 20,840 |
| Marketable Securities | 201 | 262 | 366 | 373 | N/A |
| Receivables | 5,000 | 4,608 | 3,696 | N/A | N/A |
| Other current assets | 1,912 | 820 | 2,917 | 0 | 0 |
| TOTAL | $23,022 | $19,106 | $22,375 | $16,964 | $21,333 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 18,630 | 24,855 |
| Intangibles | 1,549 | 1,549 | 1,549 | 1,549 | 1,549 |
| Other Non-Current Assets | 31,405 | 24,455 | 31,244 | 6,686 | 7,361 |
| TOTAL | $32,954 | $26,004 | $32,793 | $26,865 | $33,765 |
| Total Assets | $55,977 | $45,111 | $55,168 | $43,829 | $55,098 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,021 | 465 | 399 | 485 | 349 |
| Accrued Expenses | 521 | 596 | 2,515 | 709 | 707 |
| Other current liabilities | 35 | N/A | N/A | N/A | 3,721 |
| TOTAL | $1,577 | $1,061 | $2,914 | $1,194 | $4,776 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 25 | N/A | N/A |
| Other Non-Current Liabilities | 19,164 | 458 | 338 | 2,384 | 6,871 |
| TOTAL | $19,164 | $458 | $363 | $2,384 | $6,871 |
| Total Liabilities | $20,741 | $1,519 | $3,277 | $3,578 | $11,647 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,134 | 6,796 | 6,796 | 6,864 | 6,968 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -100,747 | -93,329 | -84,969 | -96,719 | -93,673 |
| Other shareholders' equity | 368 | 368 | 368 | -459 | -231 |
| TOTAL | $35,235 | $43,592 | $51,891 | $40,250 | $43,451 |
| Total Liabilities And Equity | $55,977 | $45,111 | $55,168 | $43,829 | $55,098 |